Advancements in the Treatment of Multiple Myeloma
Author Information
Author(s): Muacevic Alexander, Adler John R, Zavaleta-Monestel Esteban, Quesada-Villaseñor Ricardo, Barrantes-López Monserrat, Arguedas-Chacón Sebastián, Campos-Hernández Jeimy, Rojas-Chinchilla Carolina, García-Montero Jonathan, Castro-Ulloa Josué, Anchía-Alfaro Adriana, Montenegro-Chaves José Ricardo
Primary Institution: Hospital Clinica Biblica, San Jose, CRI
Hypothesis
The study explores the evolution of therapeutic strategies for multiple myeloma, focusing on the transition from traditional treatments to novel targeted therapies.
Conclusion
Recent advancements in treatment have significantly improved patient outcomes for multiple myeloma, making it more manageable and potentially curable.
Supporting Evidence
- Multiple myeloma is the second most common hematological malignancy globally.
- Recent advancements in treatment have significantly improved patient outcomes.
- Combination regimens utilizing innovative therapies have demonstrated improved efficacy.
- Targeted therapies have transformed disease management, providing deeper and more durable responses.
- Despite advancements, a definitive cure for multiple myeloma remains elusive.
Takeaway
Doctors have found better ways to treat a type of blood cancer called multiple myeloma, helping patients live longer and feel better.
Methodology
This review article was prepared through an exhaustive search of published scientific literature on the treatment of multiple myeloma, consulting databases like PubMed, Scopus, and Google Scholar.
Limitations
No statistical analysis or formal systematic review was conducted due to the descriptive nature of this narrative review article.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website